6-(1,4-Diazepan-1-yl)nicotinonitrile

Catalog No. :
ACUSXB754
CAS No. :
683274-59-1
Molecular Formula :
C11H14N4
Molecular Weight :
202.26

IUPAC Name:6-(1,4-diazepan-1-yl)nicotinonitrile

6-(1,4-Diazepan-1-yl)nicotinonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$79.00Login to see priceInquiryInquiry
1g97%$136.00Login to see priceInquiryInquiry
5g97%$457.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(1,4-Diazepan-1-yl)nicotinonitrile
IUPAC Name6-(1,4-diazepan-1-yl)nicotinonitrile
MDL No.MFCD01567269
Molecular FormulaC11H14N4
Molecular Weight202.26
SMILESN#CC1=CN=C(N2CCNCCC2)C=C1
InChI KeyAWTOGESBXYCVMV-UHFFFAOYSA-N
Synonym6-(Homopiperazin-1-yl)nicotinonitrile;BUTTPARK 37\12-48;6-(1,4-DIAZEPAN-1-YL)NICOTINONITRILE;6-(1,4-diazepan-1-yl)-3-pyridinecarbonitrile;6-(Hexahydro-1H-1,4-diazepin-1-yl)-3-pyridinecarbonitrile;3-Pyridinecarbonitrile, 6-(hexahydro-1H-1,4-diazepin-1-yl)-;6-(1,4-diazepan-1-yl)pyridine-3-carbonitrile
CAS No.683274-59-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACUSXB754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUSXB754 route product structure diagram
    ACUSXB754683274-59-1
Inquiry

2. ACUSXB754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWUTP136 route compound structure diagram
    ACWUTP13633252-28-7 In Stock
  4. Then
  5. ACUSXB754 route product structure diagram
    ACUSXB754683274-59-1
Inquiry

Comments (0)